Risk stratification, treatment selection, and transplant eligibility in multiple myeloma: a qualitative study of the perspectives and self-reported practices of oncologists.

@article{LeBlanc2016RiskST,
  title={Risk stratification, treatment selection, and transplant eligibility in multiple myeloma: a qualitative study of the perspectives and self-reported practices of oncologists.},
  author={Thomas W LeBlanc and Alexandra Howson and W Turell and Peter Sheldon and Susan C. Locke and Sascha A Tuchman and Christina Gasparetto and Satyin Kaura and Zeba M. Khan and Amy P Abernethy},
  journal={Current oncology},
  year={2016},
  volume={23 6},
  pages={e598-e604}
}
BACKGROUND Since the early 2000s, treatment options for multiple myeloma have rapidly expanded, adding significant complexity to the management of this disease. To our knowledge, no systematic qualitative research on clinical decision-making in multiple myeloma has been published. We sought to characterize how physicians view and implement guidelines and… CONTINUE READING